STOCKHOLDERS’ DEFICIT |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Stockholders Deficit | |
| STOCKHOLDERS’ DEFICIT | NOTE 5 – STOCKHOLDERS’ DEFICIT
The Company is authorized to issue authorized shares of common stock with a par value of $ as of March 31, 2025, and 2024, respectively. The Company had and issued and outstanding shares of common stock as of March 31, 2025, and 2024, respectively.
The Company previously had authorized shares of preferred stock with a par value of $, which the Company had designated as Series A Preferred Stock. As of December 31, 2023, shares of Series A Preferred Stock were issued and outstanding. In conjunction with the Merger and the Series A Preferred Stock designation the issued and outstanding shares were converted into (pre-split) shares of the Company’s common stock. The Company also has authorized shares of “blank check” preferred stock. As of March 31, 2025, the Company has t designated or issued any of these preferred shares. During the year ended December 31, 2024, the Company issued shares to adjust a discrepancy due to the reverse stock split.
|